Skip to main content

Cardlytics, Inc.

CDLX
Exchange
Nasdaq
Industry
Services-Computer Programming, Data Processing, Etc.
SEC CIK
0001666071

In the last 90 days, Cardlytics, Inc. insiders filed 0 open-market purchases and 3 sales; 43 institutions reported holding it in 13F filings for Q2 2026, worth $7.92M in total; no superinvestor holds it.

Holders of 5% or more of CDLX

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Cardlytics, Inc., largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of CDLX
HolderLatest formStakeChangeFirst filedLatest filingFiling
CAS Investment Partners, LLC13D/A9.80%5.20M shares−1.20 ppfrom 11.00%Jan 3, 20252 filingsAug 20, 2025SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

4 Schedule 13D and 13G filings on Cardlytics, Inc., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on CDLX
Filed (ET)FilerFormStakeChangeEvent dateFiling
Aug 20, 20254:00 PM ETCAS Investment Partners, LLCand 4 others13D/A9.80%5.20M shares−1.20 ppfrom 11.00%Aug 19, 2025SEC
Jul 29, 202511:23 AM ETVanguard Group Inc13G/A4.60%2.42M shares–Below 5%Jun 30, 2025SEC
Jul 16, 20257:02 PM ETBlackRock, Inc.13G/A2.10%1.10M shares–Below 5%Jun 30, 2025SEC
Jan 3, 20257:51 PM ETCAS Investment Partners, LLCand 4 others13D/A11.00%5.61M shares–Dec 31, 2024SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell Cardlytics, Inc. shares.

No Form 144 notices for Cardlytics, Inc. are on file.